Table 1.
Clinical characteristics of 32 CRC patients depending on DEGS2 expression levels.
| Feature | Degs2-high | Degs2-low | n | p |
|---|---|---|---|---|
| All cases | 16 | 16 | 32 | |
| Differentiation | 0.32 | |||
| Moderate-high | 13 | 14 | 27 | |
| Low | 3 | 1 | 4 | |
| AJCC stage | 0.0092 | |||
| Stage I & II | 7 | 14 | 21 | |
| Stage III | 9 | 2 | 11 | |
| Tumor size | 0.67 | |||
| ≤5 cm | 13 | 12 | 25 | |
| >5 cm | 3 | 4 | 7 | |
| Microvascular infiltration | 0.20 | |||
| Absent | 11 | 14 | 25 | |
| Present | 5 | 2 | 7 | |
| Ki67 positive | 0.55 | |||
| ≤60% | 5 | 7 | 12 | |
| >60% | 10 | 9 | 19 | |
| CEA | 0.012 | |||
| ≤5 ng/mL | 6 | 13 | 19 | |
| >5 ng/mL | 10 | 3 | 13 | |
| Total cholesterol | 4.66 ± 1.10 | 4.22 ± 0.71 | 0.20 | |
| Total bile acid | 5.38 ± 4.80 | 4.54 ± 3.10 | 0.60 | |
| Free fatty acid | 51.94 ± 22.66 | 45.69 ± 18.53 | 0.41 |